Single-tube protocol for culture-independent spoligotyping of Mycobacterium tuberculosis based on MeltArray.

Item request has been placed! ×
Item request cannot be made. ×
loading   Processing Request
  • Author(s): Xia Z;Xia Z; Su B; Su B; Tu C; Tu C; Sun S; Sun S; Tan Y; Tan Y; Xu Y; Xu Y; Li Q; Li Q
  • Source:
    Journal of clinical microbiology [J Clin Microbiol] 2024 Jan 17; Vol. 62 (1), pp. e0118323. Date of Electronic Publication: 2023 Dec 19.
  • Publication Type:
    Journal Article; Research Support, Non-U.S. Gov't
  • Language:
    English
  • Additional Information
    • Source:
      Publisher: American Society for Microbiology Country of Publication: United States NLM ID: 7505564 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1098-660X (Electronic) Linking ISSN: 00951137 NLM ISO Abbreviation: J Clin Microbiol Subsets: MEDLINE
    • Publication Information:
      Original Publication: Washington, American Society for Microbiology.
    • Subject Terms:
    • Abstract:
      Importance: Spacer oligonucleotide typing (spoligotyping), the first-line genotyping assay for Mycobacterium tuberculosis (MTB), plays a fundamental role in the investigation of its epidemiology and evolution. In this study, we established a single-tube spoligotyping assay using MeltArray, a highly multiplex polymerase chain reaction (PCR) approach that runs on a real-time PCR thermocycler. The MeltArray protocol included an internal positive control, gyrB , to indicate the abundance of MTB via the quantification cycle and 43 spacers to identify the spoligotype via melting curve analysis. The entire protocol was completed in a single step within 2.5 hours. The lowest detectable copy number for the tested strains was 20 copies/reaction and thus sufficient for analyzing both culture and sputum samples. We conclude that MeltArray-based spoligotyping could be used immediately in low- and middle-income countries with a high tuberculosis burden, given its easy access, improved throughput, and potential applicability to clinical samples.
      Competing Interests: The authors declare no conflict of interest.
    • References:
      Int J Mycobacteriol. 2019 Jul-Sep;8(3):211-217. (PMID: 31512595)
      J Clin Microbiol. 2018 Jan 24;56(2):. (PMID: 29118176)
      J Clin Microbiol. 1997 Apr;35(4):907-14. (PMID: 9157152)
      Infect Genet Evol. 2018 Mar;58:34-39. (PMID: 29248797)
      J Clin Microbiol. 2010 May;48(5):1520-6. (PMID: 20200291)
      J Clin Microbiol. 2004 Jan;42(1):474-7. (PMID: 14715809)
      J Microbiol Methods. 2007 Feb;68(2):430-3. (PMID: 17046089)
      Biochimie. 2024 Feb;217:66-73. (PMID: 37506757)
      J Clin Microbiol. 2012 Jul;50(7):2492-5. (PMID: 22553239)
      J Med Microbiol. 2010 Mar;59(Pt 3):285-294. (PMID: 19959631)
      Microb Pathog. 2016 Apr;93:213-8. (PMID: 26944666)
      Int J Tuberc Lung Dis. 2019 Dec 1;23(12):1314-1326. (PMID: 31931916)
      Microbiol Spectr. 2023 Jun 15;11(3):e0357022. (PMID: 37098911)
      Lancet Infect Dis. 2018 Jul;18(7):788-795. (PMID: 29681517)
      Infect Genet Evol. 2013 Jan;13:310-6. (PMID: 23183314)
      Lancet Infect Dis. 2013 Feb;13(2):137-46. (PMID: 23158499)
      J Clin Microbiol. 2007 Dec;45(12):3891-902. (PMID: 17898156)
      Infect Genet Evol. 2019 Aug;72:31-43. (PMID: 30593925)
      J Clin Microbiol. 2022 Apr 20;60(4):e0240821. (PMID: 35369709)
      J Clin Microbiol. 2016 Sep;54(9):2384-7. (PMID: 27335152)
      J Clin Microbiol. 2020 Jul 23;58(8):. (PMID: 32513858)
      Microbiol Spectr. 2018 Oct;6(5):. (PMID: 30338753)
      Lancet Infect Dis. 2017 Mar;17(3):275-284. (PMID: 27919643)
      Infect Drug Resist. 2023 Mar 08;16:1313-1326. (PMID: 36919034)
      Folia Microbiol (Praha). 2018 Sep;63(5):537-545. (PMID: 29550921)
      Proc Natl Acad Sci U S A. 2022 Mar 1;119(9):. (PMID: 35197282)
      J Clin Microbiol. 2018 Jul 26;56(8):. (PMID: 29875194)
      Anal Biochem. 1997 Feb 15;245(2):154-60. (PMID: 9056205)
      Pathog Glob Health. 2019 Dec;113(8):336-351. (PMID: 31903874)
      mBio. 2017 Aug 29;8(4):. (PMID: 28851844)
      Infect Genet Evol. 2012 Jun;12(4):755-66. (PMID: 22365971)
      New Microbes New Infect. 2020 Sep 28;38:100767. (PMID: 33204430)
      PLoS One. 2012;7(5):e36995. (PMID: 22623967)
      Microbiol Spectr. 2022 Jun 29;10(3):e0022322. (PMID: 35467406)
      BMC Infect Dis. 2018 Mar 27;18(1):140. (PMID: 29587640)
      Bioinformatics. 2017 Jan 1;33(1):128-129. (PMID: 27605102)
      J Clin Microbiol. 2023 Jun 20;61(6):e0188422. (PMID: 37195177)
      Eur Respir J. 2018 Jun 28;51(6):. (PMID: 29650560)
    • Grant Information:
      2023G051 Fujian Provincial Department of Science and Technology; 3502Z20191007 Xiamen Municipal Bureau of Science and Technology; JCYJ20180306170526435 Shenzhen Municipal Science and Technology Innovation Council; 2022CXY0113 Xiamen Municipal Bureau of Science and Technology; 2021ZD0006 Department of Science and Technology of Inner Mongolia Autonomous Region; 2021Y4001 Fujian Provincial Department of Science and Technology
    • Contributed Indexing:
      Keywords: MeltArray; Mycobacterium tuberculosis; spoligotyping; sputum
    • Publication Date:
      Date Created: 20231219 Date Completed: 20240118 Latest Revision: 20240620
    • Publication Date:
      20240620
    • Accession Number:
      PMC10793361
    • Accession Number:
      10.1128/jcm.01183-23
    • Accession Number:
      38112521